The Complete Egg Donation Guide for Women with Herpes: Eligibility, Safety, and Legal Insights

Herpes simplex virus (HSV) comes in two flavors—HSV‑1, usually oral, and HSV‑2, typically genital. Clinics screen for both because active lesions can seed infection during invasive procedures. The key eligibility question isn’t “Do you have herpes?” but rather “Do you have an outbreak right now?” Most reputable programs follow the American Society for Reproductive Medicine (ASRM) guidelines, which allow donors with a history of herpes as long as they’re lesion‑free and on suppressive therapy if needed. This nuance means a woman with a past outbreak can still move forward, provided she coordinates timing with her doctor.

A practical example: Sarah, 28, had her first genital herpes outbreak at 22. After a year of antiviral medication, she’s been outbreak‑free for 18 months. When she approached a donor clinic, the medical director requested a recent PCR test to confirm viral suppression and a signed health questionnaire. With those steps completed, Sarah was cleared to begin ovarian stimulation. Her case illustrates that a documented, stable history often satisfies the medical gatekeepers.

Current research shows no direct link between latent HSV infection and oocyte integrity. The virus resides in nerve tissue, not in the ovaries, so the genetic material of the egg remains untouched. However, systemic inflammation during an active outbreak could theoretically affect hormonal responses, making stimulation less predictable. Clinics mitigate this by scheduling retrieval only after a symptom‑free window—usually at least two weeks after the last outbreak.

Consider the scenario of a donor who experiences a mild oral herpes flare during the stimulation phase. While the oral lesion doesn’t impact the ovaries, the stress of the outbreak can alter cortisol levels, potentially dampening the response to gonadotropins. In practice, physicians may adjust medication dosages or pause the cycle until the donor’s body returns to baseline, ensuring optimal egg yield without compromising safety.

First, antiviral prophylaxis is a cornerstone. A daily dose of valacyclovir or acyclovir during the stimulation cycle reduces the chance of subclinical shedding. Clinics also require donors to avoid sexual activity that could trigger an outbreak during the critical window around retrieval. Second, strict aseptic technique during transvaginal ultrasound‑guided aspiration prevents any cross‑contamination; the needle never contacts external lesions, and the procedure is performed in a sterile field.

Third, donors should keep a symptom diary. Recording any tingling, itching, or prodromal signs helps the clinical team intervene early. If a lesion appears within 48 hours of planned retrieval, the cycle is typically cancelled and rescheduled. This approach protects both the donor’s health and the integrity of the eggs, while also respecting the recipient’s right to a clean, virus‑free product.

Transparency varies by jurisdiction and clinic policy. In the United States, the donor’s medical history—including communicable diseases—is part of the donor profile that recipients can review, but only if the donor consents to share that information. Some programs anonymize donors completely, limiting disclosure to “no known transmissible infections.” If you opt for full disclosure, the recipient will see that you have a history of herpes, but they won’t learn your identity.

If you prefer privacy, you can sign a non‑disclosure agreement that keeps your herpes status out of the recipient’s file. The clinic still records the information internally for safety and legal compliance, but it isn’t shared unless you waive that right. This flexibility lets donors balance personal privacy with the recipient’s need for medical transparency.

When you sign the donor agreement, you’ll be asked to disclose any past or present medical conditions, including herpes. Failure to do so can be considered fraud and may void the contract, exposing you to legal repercussions. However, the agreement also contains confidentiality clauses that safeguard your personal data under HIPAA in the U.S. or GDPR in Europe.

In addition, many clinics require donors to sign a release allowing the recipient to receive a summary of the donor’s health screen. This release is separate from the anonymity agreement. If a recipient later discovers an undisclosed infection, they could pursue legal action for negligence. Therefore, honesty on the questionnaire is non‑negotiable, but you retain control over how much detail is communicated beyond the essential health facts.

Antiviral drugs like valacyclovir are safe to continue throughout the stimulation cycle and may even improve outcomes by keeping viral replication at bay. Conversely, certain supplements—particularly high‑dose vitamin A or herbal immune boosters—can interact with gonadotropins and should be paused. Steroids, sometimes prescribed for severe outbreaks, can suppress the immune system and potentially affect ovarian response; they are typically avoided unless medically necessary.

If you’re on a daily suppressive antiviral regimen, inform your reproductive endocrinologist. They may adjust the timing of the last dose before retrieval to minimize any theoretical impact on the follicular environment. Most importantly, never start or stop prescription medications without consulting the clinic’s medical director, as abrupt changes can destabilize both your viral status and hormone levels.

1. Get a baseline PCR test for HSV‑1 and HSV‑2 at least four weeks before starting a cycle. 2. Discuss antiviral prophylaxis with your physician; obtain a prescription for the duration of the cycle. 3. Keep a daily log of any prodromal symptoms; report changes immediately. 4. Schedule the retrieval only after a confirmed symptom‑free period (minimum 14 days). 5. Follow strict hygiene rules: shower before appointments, avoid sexual activity that could trigger lesions, and wear loose clothing post‑retrieval.

6. Review the donor contract carefully, noting sections on disease disclosure and confidentiality. 7. Attend the post‑retrieval follow‑up to ensure proper healing and to discuss any unexpected side effects. By ticking off each item, you reduce the risk of cycle cancellation, protect the recipient’s health, and maintain your own well‑being throughout the process.

Navigating the intersection of a chronic viral infection and the emotional stakes of egg donation can be stressful. Many donors benefit from counseling that addresses both the stigma surrounding herpes and the pressures of a high‑stakes medical procedure. Support groups—both online forums and local meet‑ups—offer a space to share experiences, from timing challenges to dealing with disclosure decisions.

A practical tip: schedule a brief session with a therapist who specializes in reproductive health before your first stimulation. They can help you develop coping strategies for anxiety about outbreaks, discuss boundary setting with potential recipients, and reinforce the importance of self‑care during hormone‑intensive cycles. Mental resilience often translates into smoother medical outcomes, as a calm body responds more predictably to stimulation drugs.